Moody’s upgrades Egypt’s ratings to B3 and maintains positive outlook

By Oct 19, 2026

Moody's — Moody’s upgrades Egypt's ratings to B3 and maintains positive outlook african markets

Auto-published by the finit.news Events monitor from Moody's; summarized by AI and may contain errors — verify against the primary source. October 19, 2026.

By

Credit Ratings

Fitch lifts UniCredit Bulbank’s viability rating to ‘bbb-‘, affirms IDR at ‘A-‘

Oct 19, 2026

Credit Ratings

Fitch affirms Misr Insurance’s rating

Oct 19, 2026

Credit Ratings

Hidden AI debt risks cloud tech giants’ credit outlook

Oct 19, 2026

Regulatory Approvals

Dostarlimab Receives FDA Approval for MSI-H/dMMR Locally Advanced Rectal Cancer

Regulatory Approvals

FDA Approves Ryzumvi Eye Drops for Presbyopia

Regulatory Approvals

Haemonetics says FDA clears vascular closure device

Regulatory Approvals

Moody’s upgrades Egypt’s ratings to B3 and maintains positive outlook

By

Financial News For All

Dostarlimab Receives FDA Approval for MSI-H/dMMR Locally Advanced Rectal Cancer

FDA Approves Ryzumvi Eye Drops for Presbyopia

Haemonetics says FDA clears vascular closure device

FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery

Moody’s upgrades Egypt’s ratings to B3 and maintains positive outlook

By

Related Post

Fitch lifts UniCredit Bulbank’s viability rating to ‘bbb-‘, affirms IDR at ‘A-‘

Fitch affirms Misr Insurance’s rating

Hidden AI debt risks cloud tech giants’ credit outlook

Financial News For All

Dostarlimab Receives FDA Approval for MSI-H/dMMR Locally Advanced Rectal Cancer

FDA Approves Ryzumvi Eye Drops for Presbyopia

Haemonetics says FDA clears vascular closure device

FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery